The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 4: Pre-clinical efficacy and complication data required to justify a clinical trial

Xenotransplantation

Volumn 16, Issue 4, 2009, Pages 229-238

  Cooper, David K C ^a   Casu, Anna ^b,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

Islets of Langerhans; Pre clinical animal models; Type 1 diabetes; Xenotransplantation

Indexed keywords

ARGININE; C PEPTIDE; GLUCOSE; INSULIN;

B LYMPHOCYTE; CELL ENCAPSULATION; CONSENSUS DEVELOPMENT; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HISTOLOGY; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTRAVENOUS GLUCOSE TOLERANCE TEST; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRACTICE GUIDELINE; PRIMATE; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SWINE; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME; XENOTRANSPLANTATION;

ADULT; ANIMALS; BLOOD GLUCOSE; C-PEPTIDE; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 1; GLUCOSE TOLERANCE TEST; HUMANS; IMMUNOSUPPRESSION; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; PRIMATES; SWINE; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 70349597644     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2009.00543.x     Document Type: Review

References (25)

1. Rood PPM, Cooper DKC. Islet xenotransplantation: are we really ready for clinical trials? Am J Transplant 2006 6 : 1269 1274.
2. Rood PPM, Buhler LH, Bottino R, Trucco M, Cooper DKC. Pig-to-nonhuman primate islet xenotransplantation: a review of current problems. Cell Transplant 2006 15 : 89 104.
3. Hering BJ, Wijkstrom M, Graham ML et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006 12 : 301 303.
4. Cardona K, Korbutt GS, Milas Z et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006 12 : 304 306.
5. Rood PPM, Bottino R, Balamurugan AN et al. Reduction of early graft loss after intraportal porcine islet transplantation in monkeys. Transplantation 2007 83 : 202 210.
6. Dufrane D, Gianello P. Pig islet xenotransplantation into non-human primate model. Transplantation 2008 86 : 753 760.
7. Casu A, Bottino R, Balamurugan AN et al. Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008 51 : 120 129.
8. McCulloch DK, Raghu PK, Johnston C et al. Defects in beta-cell function and insulin sensitivity in normoglycemic streptozocin-treated baboons: a model of pre-clinical insulin-dependent diabetes. J Clin Endocrinol Metab 1988 67 : 785 792.
9. McCulloch DK, Koerker DJ, Kahn SE et al. Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons. Diabetes 1991 40 : 673 679.
10. Chavez AO, Lopez-Alvarenga JC, Tejero ME et al. Physiological and molecular determinants of insulin action in the baboon. Diabetes 2008 57 : 899 908.
11. Hara H, Lin YJ, Zhu X et al. Safe induction of diabetes by high-dose streptozotocin in pigs. Pancreas 2008 36 : 31 38.
12. Wijkstrom M, Kirchhof N, Reynolds N et al. Dosing streptozotocin based on body surface area is superior to dosing based on body weight. Int Cong Cell Transpl Soc 2003. Abstract P53.
13. Rood PPM, Bottino R, Balamurugan AN et al. Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses. Pancreas 2006 33 : 287 292.
14. Tigno XT, Gerzanich G, Hansen BC. Age-related changes in metabolic parameters of nonhuman primates. J Gerontol A Biol Sci Med Sci 2004 59 : 1081 1088.
15. Schuurman HJ. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 2: Source pigs. Xenotransplantation 2009 16 215 222.
16. Dufrane D, Goebbels RM, Saliez A, Guiot Y, Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 2006 81 : 1345 1353.
17. Buhler L, Deng S, O'Neil J et al. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002 9 : 3 13.
18. Tseng YL, Sachs DH, Cooper DKC. Porcine hematopoietic progenitor cell transplantation in nonhuman primates: a review of progress. Transplantation 2005 79 : 1 9.
19. The DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987 65 : 30 36.
20. Palmer JP, Fleming GA, Greenbaum CJ et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA Workshop, 21-22 October 2001. Diabetes 2004 53 : 250 264.
21. Robertson RP. Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient? Diabetes 2007 56 : 2420 2424.
22. Rickels MR, Schutta MH, Markmann JF et al. (beta)-Cell function following human islet transplantation for type 1 diabetes. Diabetes 2005 54 : 100 106.
23. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1984 74 : 1318 1328.
24. Greenspan FS, Gardner DG. Normal hormone reference ranges. In : Reinhardt S, Boyle PJ, Ransom J, eds. Lange Endocrinology - Basic and Clinical Endocrinology, 7th edn. New York : McGraw-Hill, 2006 : 920 938.
25. Genuth S, Alberti KG, Bennett P et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 : 3160 3167.